Loading chat...

HI HB2630

Bill

Status

Introduced

1/24/2024

Primary Sponsor

Della au Belatti

Click for details

Origin

House of Representatives

2024 Regular Session

AI Summary

HB 2630 Summary

  • Authorizes therapeutic use of psilocybin for qualifying patients with debilitating mental health conditions including depression, anxiety, PTSD, addiction, and eating disorders, with a licensed medical professional's written certification.

  • Limits psilocybin administration to a maximum of 5 grams per session and requires patients to complete preparation, administration, and integration sessions with a trained facilitator.

  • Establishes facilitator eligibility requirements including age 21+, high school diploma, state residency, and completion of a department-approved psychedelic integration training program.

  • Provides legal protections for qualifying patients, primary caregivers, and licensed medical professionals who comply with the law, allowing therapeutic use as an affirmative defense to drug possession charges.

  • Prohibits therapeutic use in schools, workplaces, public spaces, vehicles, and other public areas; creates penalties for fraudulent misrepresentation or non-compliant medical certifications.

Legislative Description

Relating To Mental Health Treatment.

Authorization

Last Action

Report adopted. referred to the committee(s) on FIN as amended in HD 2 with none voting aye with reservations; Representative(s) Alcos, Garcia, Kila, Kitagawa, Lamosao, Matayoshi, Matsumoto, Pierick, Ward voting no (9) and Representative(s) Aiu, Garrett, Perruso, Takayama, Todd excused (5).

2/16/2024

Committee Referrals

Finance2/16/2024
Consumer Protection & Commerce2/8/2024
Judiciary & Hawaiian Affairs1/26/2024

Full Bill Text

No bill text available